Most bought healthcare stocks in Q2 2001

See which Healthcare stocks institutional investors increased the most in Q2 2001, measured as net growth in reported share positions from Q1 2001 into Q2 2001. Notable additions at the top of this list include BOSTON SCIENTIFIC CORP (BSX), JOHNSON & JOHNSON (JNJ), ABBOTT LABORATORIES (ABT), PFIZER INC (PFE). These rankings aggregate SEC 13F filings from all institutional investors in our database.

Explore more:

Net change in reported shares (all institutional filers) by symbol6 symbols with net change in reported shares from all institutional filers.0.001.6K3.1K4.7K6.3KNet change in reported shares (all institutional filers)BSXJNJABTPFECAHBMYSymbol
SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
BSXBOSTON SCIENTIFIC CORP5,700$1.50K01001
JNJJOHNSON & JOHNSON4,370$218.50K10001
ABTABBOTT LABORATORIES4,200$201.60K10001
PFEPFIZER INC2,250$82.87K01001
CAHCARDINAL HEALTH INC1,750$23.63K01001
BMYBRISTOL-MYERS SQUIBB CO400-$104.18K01001

Frequently asked questions about Most bought healthcare stocks in Q2 2001

  • What are the most bought Healthcare stocks in Q2 2001?

    The most bought healthcare stocks in Q2 2001 are those with the largest increase in reported share counts across institutional investors compared to Q1 2001, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q2 2001?

    Among filers in this sector, net additions were largest in companies such as BOSTON SCIENTIFIC CORP (BSX), JOHNSON & JOHNSON (JNJ), ABBOTT LABORATORIES (ABT), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2001).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.